Ausejo, Ayesha Kendra E.

HRN: 26-44-16  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2026
CEFUROXIME 750MG (VIAL)
03/18/2026
03/25/2026
IV
250MG
Q8h
PCAP C
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines